By Turna Ray

Following multiple accounts from payors about rising levels of inappropriate BRCA testing to gauge which women are at higher hereditary risk for breast and ovarian cancer, national insurer Aetna said last week that it will survey testing patterns among women treated in a community healthcare setting. The findings of the two-year study, which payors will surely be closely reviewing, could impact how BRACAnalysis, Myriad Genetics' flagship product, is covered by insurers.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Five researchers are to share this year's Albany Medical Center Prize for their work on the CRISPR/Cas9 gene-editing tool, the AP reports.

Stat News reports on how white supremacists cope with surprising genetic ancestry testing results.

In Genome Research this week: sex-biased gene expression evolution in malaria mosquitos, method to find ancient selective sweeps, and more.

Iceland has nearly eliminated Down syndrome from its population, CBS News reports.